Impact of GBS on CVD in Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
ObesityType 2 Diabetes Mellitus
Interventions
OTHER

Diabetes Support and Education

The subjects will attend three educational/social support sessions for 1 year after enrollment. The educational sessions include informational sessions on diet/nutrition and exercise. These sessions are informational and do not teach behavioral self-regulation skills.

PROCEDURE

gastric bypass surgery

gastric bypass surgery to induce weight loss in obese patients with type 2 diabetes

OTHER

Tissue Control Group

During the abdominal surgery we would like to take 5 ml blood from the IV line and small pea-sized samples of the fat tissue just under the skin and around the stomach area. These samples will be stored so that we can compare these tissue with other patients.

Trial Locations (1)

27704

Duke University Health system, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Duke University

OTHER

NCT00787670 - Impact of GBS on CVD in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter